Literature DB >> 11331491

Clinical features of systemic sclerosis.

R N Al-Adhadh1, T A Al-Sayed.   

Abstract

OBJECTIVE: This descriptive study was carried out to determine the clinical and epidemiological pattern of systemic sclerosis in Iraqi patients who prove to have the disease.
METHODS: Between March 1997 and December 1999, 75 patients, 67 females and 8 males, were studied at 2 teaching hospitals in Baghdad, Iraq. The diagnosis of the disease was based on clinical findings, biochemical, serological, and pulmonary function tests.
RESULTS: All the patients had Raynaud's phenomenon, 72 (96%) had arthralgia, 65 (87%) had dysphagia, 62 (83%) had atrophic changes or hypo/hyperpigmentation, 43 (58%) had telangiectasia, and 3 (4%) had subcutaneous calcification. Of the patients studied, 2 patients (3%) had hypertension, one had severe hypertension. Twenty-three patients (31%) had anemia, 58 (77%) had elevated erythrocyte sedimentation rate and 7 patients (9%) with renal impairment. Rheumatoid factor was positive in 17 patients (23%) and antinuclear antibody in 50 (67%). Abnormal chest x-ray was reported in 50 patients (67%). Pulmonary function tests showed restrictive pattern in 53 (71%) patients and obstructive pattern in 3 (4%). Electrocardiogram changes were seen in 3 (4%) of the patients. Three juvenile cases were reported, and familial tendency was noted in one patient. The results were compared with other studies and there were interesting differences and similarities.
CONCLUSION: Systemic sclerosis is a rare disease in Iraq, nevertheless sporadic cases at a peak age of 20-40 years were reported. Generally the clinical picture was comparable to other studies, however Raynaud's phenomenon is more prevalent in our patients and antinuclear antibody is less common.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11331491

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  6 in total

Review 1.  Systemic sclerosis: a world wide global analysis.

Authors:  Paola Coral-Alvarado; Aryce L Pardo; Natalia Castaño-Rodriguez; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  Clin Rheumatol       Date:  2009-03-11       Impact factor: 2.980

2.  Mucocutaneous and demographic features of systemic sclerosis: a profile of 46 patients from eastern India.

Authors:  Sudip Kumar Ghosh; Debabrata Bandyopadhyay; Indranil Saha; Jayanta Kumar Barua
Journal:  Indian J Dermatol       Date:  2012-05       Impact factor: 1.494

3.  Alterations of mononuclear inflammatory cells, CD4/CD8+ T cells, interleukin 1beta, and tumour necrosis factor alpha in the bronchoalveolar lavage fluid, peripheral blood, and skin of patients with systemic sclerosis.

Authors:  M R Hussein; H I Hassan; E R M Hofny; M Elkholy; N A Fatehy; A E A Abd Elmoniem; A M Ezz El-Din; O A Afifi; H G Rashed
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

4.  Anti-annexin v antibodies: association with vascular involvement and disease outcome in patients with systemic sclerosis.

Authors:  Reem A Habeeb; Howaida E Mansour; Aya M Abdeldayem; Rania A Abo-Shady; Iman A Hassan; Nazek K Saafan; Dalia G Aly
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2010-04-28

Review 5.  The Videofluorographic Swallowing Study in Rheumatologic Diseases: A Comprehensive Review.

Authors:  Ambra Di Piazza; Federica Vernuccio; Massimo Costanzo; Laura Scopelliti; Dario Picone; Federico Midiri; Francesco Salvaggi; Francesco Cupido; Massimo Galia; Sergio Salerno; Antonio Lo Casto; Massimo Midiri; Giuseppe Lo Re; Roberto Lagalla
Journal:  Gastroenterol Res Pract       Date:  2017-06-15       Impact factor: 2.260

6.  Clinical and serological characteristics of systemic sclerosis: Experience of a tertiary care center in Pakistan.

Authors:  Sadia Asif; Asadullah Khan; Muhammad Faiq; Zia Ud Din; Sarmad Zahoor; Muhammad Haroon
Journal:  Arch Rheumatol       Date:  2021-10-24       Impact factor: 1.472

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.